Dublin, Ireland

Darren Fayne

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Trinity College Dublin. Active years: 2016-2018.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Darren Fayne

Introduction

Darren Fayne, an accomplished inventor based in Dublin, Ireland, has made significant strides in the field of pharmaceutical innovations. With a total of two patents to his name, Fayne's work primarily focuses on the development of compounds that address critical medical conditions.

Latest Patents

Fayne's latest patents include notable contributions to the medical field. The first patent revolves around 3-phenyl-7-hydroxy-isocoumarins as macrophage migration inhibitory factor (MIF) inhibitors. These compounds serve as MIF inhibitors with compositions and methods that have potential applications in treating or preventing diseases associated with MIF. The second patent involves the creation of non-ligand binding pocket antagonists for the human androgen receptor. This innovative approach addresses the treatment of androgen-dependent conditions, including prostate cancer, by providing alternatives to classical therapies that can lead to androgen resistance.

Career Highlights

Darren Fayne's career has been enriched by his association with prestigious institutions. He has worked with The Provost, Fellows, Foundation Scholars, and the Other Members of the Board of the College of the Holy and Undivided Trinity of Queen Elizabeth, near Dublin. His academic and research contributions have been instrumental in advancing the understanding of androgen receptor modulation and its implications for therapeutic strategies.

Collaborations

Throughout his career, Fayne has collaborated with esteemed colleagues, including Seamas Donnelly and David Lloyd. These partnerships have fostered an environment of innovation and have contributed to the development of groundbreaking therapeutic solutions.

Conclusion

Darren Fayne’s innovative efforts in pharmaceuticals highlight his dedication to addressing significant health challenges. His patents reflect a commitment to advancing medical treatments, showcasing the impact of innovation in the field of medicine. As he continues to contribute to the world of science, his work serves as an inspiration for aspiring inventors and researchers alike.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…